Institutional investors hold a majority ownership of BMY through the 70.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2017, these large investors purchased a net $16.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LPL FINANCIAL LLC Bought 466.0 Thousand shares of Bristol-Myers Squibb